Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphopenia × Fingolimod Hydrochloride × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Lymphopenia 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Astrocytoma 1

Interventions

Interleukin-7 2 efineptakin alfa 1 Transplantation 1 Thymalfasin 1 Sodium Chloride 1 SARS-CoV-2 inactivated vaccines 1 Radiotherapy 1 Peripheral Blood Stem Cell Transplantation 1 Injections 1 Fingolimod Hydrochloride 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02490930 2017-09-13

A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase EARLY_PHASE1 Completed

Astrocytoma, Glioblastoma, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡